Yangtze River Pharmaceutical Group Co., Ltd.
USPTO PatentsView assignee record - 22 granted patents across 6 technology areas, recorded in grant years 2018–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Yangtze ranks #13,807 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 6 technology areas.
- #13,807
- of 49,997 US assignees by volume
- 28th percentile
- by Innovation Score (28.7/100)
- 15.3
- avg claims per patent
- +114%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13807 · Foreign Corporation #13,807 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 22 grants
- MID-PACK #13,807/49,997
- PHOTO-FINISH Xiamen Innovax Biotech
- CPC-NARROW A61P · 6 areas
- INNOV-THIN 28.7/100
- CLAIMS-RICH 15.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +114% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Xiamen Innovax Biotech Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Yangtze’s 28.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Yangtze
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- CAN Mobilities · near 29
CAN Mobilities · near
29 score
- Pregis · near 29
Pregis · near
29 score
- Yangtze River… · this assignee 29
Yangtze River… · this assignee
29 score
- Arktura · near 29
Arktura · near
29 score
- ZON · near 29
ZON · near
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Yangtze's Innovation Score is 28.7/100 (28th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Yangtze?
Each dot is one of Yangtze’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Yangtze’s own 15.3 claims/patent is ABOVE the 9.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Yangtze's grants concentrate
Yangtze River Pharmaceutical Group Co., Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 95.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (8 grants) versus a trough of 2 in 2019. By volume, Yangtze sits between Xiamen Innovax Biotech Co., Ltd. and Zhuhai Cosmx Battery Co., Ltd..
Who files at Yangtze's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Xiamen Innovax Bi…
Xiamen Innovax Biotech Co., Ltd.
22 patents
- Xiamen Sheep Anti…
Xiamen Sheep Anti-Fatigue Mat Co., Ltd.
22 patents
- Y-brain
Y-brain Inc.
22 patents
- Yamagata Universi…
Yamagata University
22 patents
- Yeti Cycling
Yeti Cycling, LLC
22 patents
- Yong Kang Aijiu I…
Yong Kang Aijiu Industrial & Trade Co., Ltd
22 patents
- Zhongshan SHI Son…
Zhongshan SHI Songlin Furniture Co., Ltd.
22 patents
- Zhuhai Cosmx Batt…
Zhuhai Cosmx Battery Co., Ltd.
22 patents
- Yangtze River Pha… ◀
Yangtze River Pharmaceutical Group Co., Ltd.
22 patents
What this shows Yangtze holds 22 patents at rank #13,803, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Yangtze
By rank, the assignees closest to #13,803 in granted patent volume.
- Xiamen Innovax Biotech Co., Ltd. #13,799 · 22 patents
- Xiamen Sheep Anti-Fatigue Mat Co., Ltd. #13,800 · 22 patents
- Y-brain Inc. #13,801 · 22 patents
- Yamagata University #13,802 · 22 patents
- Yeti Cycling, LLC #13,804 · 22 patents
- Yong Kang Aijiu Industrial & Trade Co., Ltd #13,805 · 22 patents
- Zhongshan SHI Songlin Furniture Co., Ltd. #13,806 · 22 patents
- Zhuhai Cosmx Battery Co., Ltd. #13,807 · 22 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Yangtze's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Yangtze, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Yangtze ranks #933 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (29 here).
Yangtze's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 28th percentile higher than 28% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 5 | 22.7% |
| 2019 | 2 | 9.1% |
| 2020 | 7 | 31.8% |
| 2021 | 8 | 36.4% |
Which technologies does Yangtze River Pharmaceutical Group Co., Ltd. patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Yangtze River Pharmaceutical Group Co., Ltd.'s patent record in context - here's where to go next.
- Yangtze River Pharmaceutical Group Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 95.5% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #13,807 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Yangtze River Pharmaceutical Group Co., Ltd. against Xiamen Innovax Biotech Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 28.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.